RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 59 filers reported holding RENEO PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.29 and the average weighting 1.0%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RiverVest Venture Management LLC | 2,534,220 | $19,298,085 | 47.73% |
NEA Management Company, LLC | 4,785,494 | $36,441,537 | 2.81% |
Aisling Capital Management LP | 886,075 | $6,743,031 | 2.78% |
Octagon Capital Advisors LP | 2,279,870 | $17,361,210 | 2.67% |
Novo Holdings A/S | 3,330,377 | $25,344,169 | 1.87% |
GREAT POINT PARTNERS LLC | 1,167,061 | $8,887,170 | 1.62% |
Carlyle Group Inc. | 2,698,957 | $20,539,063 | 0.89% |
Eventide Asset Management | 2,078,142 | $15,825,051 | 0.28% |
Rock Springs Capital Management LP | 1,143,185 | $8,705,354 | 0.23% |
First Light Asset Management, LLC | 272,317 | $2,073,694 | 0.20% |
J. Goldman & Co LP | 155,410 | $1,183,447 | 0.04% |
Woodline Partners LP | 450,646 | $3,431,669 | 0.04% |
ExodusPoint Capital Management, LP | 378,977 | $2,886 | 0.03% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 91,380 | $695,859 | 0.02% |
MAI Capital Management | 123,720 | $942,128 | 0.01% |
Pale Fire Capital SE | 14,851 | $113,090 | 0.01% |
Dorsey Wright & Associates | 3,673 | $27,970 | 0.01% |
PRELUDE CAPITAL MANAGEMENT, LLC | 14,800 | $112,702 | 0.01% |
FRANKLIN RESOURCES INC | 1,493,356 | $11,371,906 | 0.01% |
Trexquant Investment LP | 20,761 | $158,095 | 0.00% |
External links
This page lists RENEO PHARMACEUTICALS INC's shareholders in Q3 2023. To view RENEO PHARMACEUTICALS INC's shareholder history, click here.